Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB340614

IL-29/IFN-lambda 1 Antibody (B-S29), mFluor Violet 610 SE, Novus Biologicals™
SDP

Catalog No. NB340614 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB340614 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB340614 Supplier Novus Biologicals Supplier No. NBP318106MFV610
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

IL-29/IFN-lambda 1 Monoclonal antibody specifically detects IL-29/IFN-lambda 1 in Human samples. It is validated for ELISA

Specifications

Antigen IL-29/IFN-lambda 1
Applications ELISA
Classification Monoclonal
Clone B-S29
Conjugate mFluor Violet 610 SE
Dilution ELISA
Formulation 50mM Sodium Borate
Gene Alias cytokine Zcyto21, IFNL1, IFN-lambda-1, IL-29, interferon lambda-1, interferon, lambda 1, interleukin 29 (interferon, lambda 1), interleukin-29, ZCYTO21
Host Species Mouse
Immunogen Recombinant human IL-29/IFN-lambda 1. Hybridoma: Myeloma X63/AG.8653 x Balb/c node cells
Purification Method Affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Biologically Active Proteins
Primary or Secondary Primary
Gene ID (Entrez) 282618
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG2b κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.